BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/9/2026 8:15:15 AM | Browse: 50 | Download: 74
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 121827
Country China
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title PARVA promotes gastric cancer progression through FBXO15-related PI3K/AKT signaling
Manuscript Source Unsolicited Manuscript
All Author List Xu Lu, Jing Li, Ming-Liang Wang, Hui-Zhen Wang and Yong-Xiang Li
ORCID
Author(s) ORCID Number
Xu Lu http://orcid.org/0009-0006-8124-6310
Jing Li http://orcid.org/0009-0006-4499-5427
Ming-Liang Wang http://orcid.org/0000-0002-4830-9467
Yong-Xiang Li http://orcid.org/0000-0001-7183-9485
Funding Agency and Grant Number
Funding Agency Grant Number
the University Fund Project of Anhui Medical University 2023xkj093
Corresponding Author Yong-Xiang Li, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Shushan District, Hefei 230022, Anhui Province, China. liyongxiang@ahmu.edu.cn
Key Words Gastric cancer; PARVA; FBXO15; PI3K/AKT; Proliferation; Migration; Invasion
Core Tip PARVA was identified from previous proteomic screening and validated in gastric cancer. PARVA was upregulated in tumor tissues and cell lines, and high expression was associated with shorter overall survival. Functional assays showed that PARVA promoted proliferation, migration, invasion, and xenograft growth. Mechanistically, PARVA was associated with FBXO15 and activation of the PI3K/AKT pathway. These findings support PARVA as a candidate biomarker and potential therapeutic target requiring further validation.
Publish Date 2026-10-09 08:15
Citation

Lu X, Li J, Wang ML, Wang HZ, Li YX. PARVA promotes gastric cancer progression through FBXO15-related PI3K/AKT signaling. World J Gastrointest Oncol 2026; 18(10): 121827

URL https://www.wjgnet.com/1948-5204/full/v18/i10/121827.htm
DOI https://doi.org/10.4251/wjgo.121827
Full Article (PDF) WJGO-18-121827-with-cover.pdf